{
    "filename": "S0166354220301145.pdf",
    "content_type": "text/html",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1016/j.antiviral.2020.104762",
            "url": "https://dx.doi.org/10.1016/j.antiviral.2020.104762"
        },
        "doi": "10.1016/j.antiviral.2020.104762",
        "title": "Of chloroquine and COVID-19",
        "journal": "Antiviral Research",
        "volume": "177",
        "abstract": "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.",
        "author": "Franck Touret, Xavier de Lamballerie",
        "date": 2020,
        "pages": "104762",
        "references": "",
        "references_ris": "",
        "links": [],
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": []
    },
    "structured_content": {
        "Abstract": [
            "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."
        ]
    },
    "participants": [],
    "statistics": [],
    "keywords": [
        "sars cov",
        "possible benefit",
        "coronavirus",
        "antiviral research",
        "previous experiment",
        "scientific community",
        "antimalarial drug",
        "recent publication"
    ],
    "keyword_relevance": {
        "possible benefit": 0.15384615384615385,
        "coronavirus": 0.15384615384615385,
        "antiviral research": 0.15384615384615385,
        "previous experiment": 0.15384615384615385,
        "scientific community": 0.15384615384615385,
        "antimalarial drug": 0.15384615384615385,
        "recent publication": 0.07692307692307693,
        "sars cov": 0.0
    },
    "species": [],
    "summary": [
        "Chloroquine has shown in vitro activity against many different viruses, but no benefit in animal models.",
        "Chloroquine has been proposed several times for the treatment of acute viral diseases in humans without success.",
        "The outcomes of some current clinical trials of chloroquine in China have been announced, without access to the data.",
        "Peer review of the results and an independent assessment of the potential benefit for patients are essential.",
        "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2).",
        "The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."
    ],
    "structured_summary": {
        "Introduction": [
            "Chloroquine has shown in vitro activity against many different viruses, but no benefit in animal models."
        ],
        "Results": [
            "Chloroquine has been proposed several times for the treatment of acute viral diseases in humans without success.",
            "The outcomes of some current clinical trials of chloroquine in China have been announced, without access to the data.",
            "Peer review of the results and an independent assessment of the potential benefit for patients are essential.",
            "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2)."
        ],
        "Conclusion": [
            "The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."
        ]
    },
    "reference_links": [],
    "facts": [
        "in the treatment of patients infected by the novel emerged coronavirus",
        "The scientific community should consider this information in light of previous experiments"
    ],
    "claims": [],
    "findings": [],
    "processes": [],
    "key_statements": [
        "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2)",
        "The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research"
    ],
    "top_statements": [
        "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2)",
        "The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research"
    ],
    "headline": "Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus",
    "contexts": [],
    "abbreviations": {}
}
